Related Experiment Video
Updated: Jun 23, 2026
09:04
Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus
Published on: March 28, 2025
Slc1a2-mediated Glutamate Transport Promotes Dendritic Cell Immunity through Sema3A-regulated Cytoskeletal Remodeling
Shanlin Chen1, Bei Chen1, Gongwei Li1
1Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
International Journal of Biological Sciences
|June 22, 2026
Summary
Activated dendritic cells (DCs) use Slc1a2 to uptake glutamate, enhancing their migration and boosting antitumor immunity. This process involves glutamate signaling, Sema3A, and GTPase pathways crucial for immune responses.
Area of Science:
- Immunology
- Cell Biology
- Neuroscience
Background:
- Dendritic cells (DCs) are crucial for initiating antitumor immune responses through T cell activation.
- DC migration from tumors to lymph nodes is essential for effective antitumor immunity.
- The role of amino acid transporters, like Slc1a2, in immune cell function is largely unexplored.
Purpose of the Study:
- To investigate the function of Slc1a2 in dendritic cells.
- To elucidate the role of glutamate metabolism in DC migration and antitumor immunity.
- To identify molecular mechanisms linking glutamate signaling to DC function.
Main Methods:
- Analysis of Slc1a2 expression in activated DCs.
- Assessment of glutamate uptake by DCs.
- Investigation of Sema3A and small GTPase signaling pathways.
- Evaluation of DC migration and antitumor vaccine potency in vivo.
Main Results:
- Activated DCs upregulate Slc1a2, increasing glutamate uptake.
- Glutamate uptake enhances DC functionality and antitumor vaccine potency.
- Glutamate signaling induces Sema3A, activating small GTPase pathways (RhoA/Rac1/Cdc42).
- This signaling cascade drives cytoskeletal remodeling essential for DC migration.
Conclusions:
- Slc1a2-mediated glutamate metabolism acts as a metabolic checkpoint for DC migration and antitumor immunity.
- The Sema3A/small GTPase axis is a key mechanism connecting glutamate signaling to cytoskeletal reorganization in DCs.
- Targeting this pathway could enhance DC-mediated antitumor immune responses.
